Observational studyMedicina (Kaunas, Lithuania)2024

Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients.

Akiko Kin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.